Augnition Labs

Augnition Labs was launched in 2020 with the mission of developing AI-powered digital assessment and monitoring solutions for early detection of cognitive decline. As the world’s population continues to age, the number of people living with dementia is expected to rise to more than 153 million by 2050. Alzheimer's disease is the most common type of dementia. It is a progressive neurological illness, beginning with memory loss and leading to compromised thinking, language and decision making. Memory Loss comes first. As the search continues for successful therapies that treat or prevent Alzheimer’s disease, one thing is certain – sensitive detection of the disease’s earliest symptoms is key to effective intervention. Augnition Labs is working to build products that address this area of need. Read more about the science on our website.